Fellowship · Boston, MA
Sponsored by Tufts Medical Center
Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.
The New England journal of medicine · 2023 · 219 citations · Lee Hartner
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial.
Lancet (London, England) · 2024 · 75 citations · Lee Hartner
A Call to Action: Using Curriculum Mapping at Four Medical Schools in Massachusetts to Advance Serious Illness Communication Training in Undergraduate Medical Education.
Journal of palliative medicine · 2024 · 6 citations · Tamara Vesel
Achieving Equity in Telehealth: "Centering at the Margins" in Access, Provision, and Reimbursement.
Journal of the American Board of Family Medicine : JABFM · 2021 · 31 citations · Kaleigh Timmins
Curricular Reform in Serious Illness Communication and Palliative Care: Using Medical Students' Voices to Guide Change.
Academic medicine : journal of the Association of American Medical Colleges · 2024 · 8 citations · Tamara Vesel
Incorporating palliative care principles to improve patient care and quality of life in urologic oncology.
Nature reviews. Urology · 2021 · 35 citations ·
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 41 citations · Lee Hartner
Onset and resolution of ovarian toxicity with nirogacestat treatment in females with desmoid tumors: Updated safety analyses from the DeFi phase 3 study.
Cancer · 2024 · 12 citations · Lee Hartner